Loading…
Chinese AI-powered drug-delivery biotech building lipid-nanoparticle and nanomaterial platforms (NanoForge) for new drug formulations.
Chinese AI-powered drug-delivery biotech building lipid-nanoparticle and nanomaterial platforms (NanoForge) for new drug formulations.
In one line: A Chinese Moderna-style AI/lipid-nanoparticle drug-delivery platform.
Moat: narrow (IP / patents, data, process know-how). Proprietary AI+quantum-chemistry nanomaterial design platform, but drug-delivery pipeline still early-stage.
Headquarters: China
Size Metis TechBio (7666.HK) is a Hong Kong Materials company (Chemicals: Major Diversified) with a market value of $1.66B, the 464th largest of 891 Hong Kong companies the cockpit tracks. Shares closed at HK$10.99 on 6 Nov 2026.
Growth Revenue grew 6,987.0% over the last twelve months (peer median +5.7%); the operating margin is -367.1% (peer median 9.3%).
Valuation It trades at 86.8× enterprise value to sales against a peer median of 2.4× (most expensive of 21).
Capital Return on invested capital runs 99.1 points below its cost of capital (5.3% WACC).
Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | n/a | HK$114M | HK$1.61M | HK$10.3M | HK$644,235 |
| Revenue growth | — | +6,987% | -84% | +1,502% | — |
| Gross profit | n/a | HK$75.2M | -HK$36.2M | -HK$35.3M | -HK$7.93M |
| EBITDA | n/a | -HK$381M | -HK$372M | -HK$395M | -HK$439M |
| Net income | n/a | -HK$425M | -HK$541M | -HK$643M | -HK$596M |
| Free cash flow | n/a | -HK$152M | -HK$263M | -HK$267M | -HK$228M |
| Capital expenditure | n/a | HK$20.6M | HK$3.94M | HK$62.4M | HK$67.3M |
| Total debt | n/a | HK$146M | HK$2.49B | HK$2.42B | HK$753M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g |
|---|---|---|---|---|---|---|
| Metis TechBio 7666.HK | $1.66B | n/a | +6,987% | -367% | 86.8× | n/a |
| Moderna MRNA | $101B | +43% | -28% | -149% | 43.8× | n/a |
| XtalPi 2228.HK | $3.35B | -34% | +4% | -127% | 26.3× | n/a |
| Arcturus Therapeutics ARCT | n/a | +12% | n/a | n/a | n/a | n/a |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 7666.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -34.8% | -12.0% | lowest of 21 |
| Distance from 52-week high | -63.3% | -34.8% | lowest of 21 |
| Revenue growth (TTM) | +6,987.0% | +5.7% | highest of 21 |
| Operating margin | -367.1% | 9.3% | lowest of 21 |
| EV / Sales | 86.8× | 2.4× | most expensive of 21 |
| ROIC minus cost of capital | -99.1 pp | -0.4 pp | lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Metis TechBio 7666.HK | Hong Kong | $1.66B | n/a | +6,987% | -367% | 86.8× | n/a | n/a |
| Valiant 002643.SZ | China | $1.66B | -28% | +3% | 10% | 3.2× | 17.4% | +4.9% |
| Huntsman HUN | United States | $1.66B | -37% | +6% | 0% | 0.7× | n/a | n/a |
| Nippon Kayaku 4272.T | Japan | $1.66B | +3% | +14% | 10% | 1.1× | -4.8% | +6.9% |
| Fine Organic Industries FINEORG.NS | India | $1.64B | +9% | +13% | 20% | 5.5× | 26.7% | +15.7% |
| Borregaard BRG.OL | Norway | $1.68B | +7% | +3% | 17% | 2.2× | -1.0% | +7.7% |
| AARTI Industries AARTIIND.NS | India | $1.71B | -9% | +40% | 9% | 2.0× | n/a | n/a |
| Advanced Echem Materials 4749.TWO | Taiwan | $1.72B | -39% | +19% | 25% | 11.5× | n/a | n/a |
| Alzchem ACT0.DE | Germany | $1.56B | n/a | +5% | 16% | 2.3× | -1.1% | +8.2% |
| Innospec IOSP | United States | $1.93B | -3% | +5% | 8% | 0.9× | 4.4% | +8.3% |
| Jilin Chemical Fibre Stock 000420.SZ | China | $1.42B | -25% | +11% | 5% | 2.9× | n/a | n/a |
| Privi Speciality Chemicals PRIVISCL.NS | India | $1.40B | -4% | +18% | 20% | 5.1× | 30.1% | +15.0% |
| Rianlon 300596.SZ | China | $1.39B | -7% | +11% | 11% | 1.8× | n/a | n/a |
| Jiangsu Shuangxing Color Plastic New Materials 002585.SZ | China | $1.38B | +5% | -4% | -4% | 2.2× | 22.5% | +0.2% |
| Shanghai Emperor of Cleaning Hi-Tech 603200.SS | China | $1.37B | -16% | +4% | -8% | 18.4× | n/a | n/a |
| Qingdao Huicheng Environmental Technology 300779.SZ | China | $2.02B | -9% | -13% | 5% | 16.6× | n/a | n/a |
| Isuspecialtychemical 457190.KS | South Korea | $1.36B | -49% | +14% | 3% | 4.8× | n/a | n/a |
| China Resources Chemical Innovative Materials 301090.SZ | China | $1.35B | -33% | +4% | 1% | 0.5× | 21.4% | +1.1% |
| Zhejiang Yongtai Technology 002326.SZ | China | $2.04B | -40% | +38% | 11% | 2.6× | n/a | n/a |
| Eternal Materials 1717.TW | Taiwan | $2.06B | -27% | -2% | 5% | 2.0× | 19.9% | +1.2% |
| Ingevity NGVT | United States | $2.07B | -21% | -12% | 25% | 2.6× | -0.9% | -0.8% |